EMT in cervical cancer: Its role in tumour progression and response to therapy

被引：247
|
作者：
Qureshi, Rehana [1 ]
Arora, Himanshu [2 ]
Rizvi, M. A. [1 ]
机构：
[1] Jamia Millia Islamia, Dept Biosci, Genome Biol Lab, New Delhi 110025, India
[2] Univ Strasbourg, ESBS API Pole, CNRS, IREBS UMR7242, F-67412 Illkirch Graffenstaden, France
来源：
CANCER LETTERS | 2015年 / 356卷 / 02期
关键词：
Epithelial Mesenchymal Transition; Mesenchymal transition (EMT); Therapeutics; Oncogene; Tumour-suppressor; Cervical cancer; EPITHELIAL-MESENCHYMAL TRANSITION; ASTROCYTE-ELEVATED GENE-1; NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; LYMPH-NODE METASTASIS; FUSED TOES HOMOLOG; CELL-MIGRATION; E-CADHERIN; DOWN-REGULATION; MIR-200; FAMILY;
D O I：
10.1016/j.canlet.2014.09.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The prognosis of cervical patients significantly decreases as the cancer metastasizes to other parts of the body. The epithelial to mesenchymal transition (EMT) plays an important role in cervical cancer progression and metastasis. Recurrence is the primary cause of the increased number of deaths due to cervical cancer. Oncogenes, such as AEG1, Sam-68, FTS and miR-361-5p, induce EMT in cervical cancer. Tumour suppressors, such as LMX-1, SFRP1, klotho, and miR-155, suppress EMT in cervical cancer. Factors such as hypoxia, the radiation dose, cytokines, proteins, transcription factors, and signalling pathways also play an important role in the induction, progression and maintenance of EMT in cervical cancer. Overall, this review describes a wide range of factors with potential roles in EMT that have been identified to date, and this information could be important for the development of new and more effective therapeutics that ameliorate the negative impact of cervical pathogenesis via EMT. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：321 / 331
页数：11
相关论文
共 50 条
  • [41] Exploring the role of EMT in ovarian cancer progression using a multiscale mathematical model
    Samuel Oliver
    Michael Williams
    Mohit Kumar Jolly
    Deyarina Gonzalez
    Gibin Powathil
    npj Systems Biology and Applications, 11 (1)
  • [42] The role of SPET and PET in monitoring tumour response to therapy
    Chariklia Giannopoulou
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 1173 - 1200
  • [43] The role of SPET and PET in monitoring tumour response to therapy
    Giannopoulou, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (08) : 1173 - 1200
  • [44] Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response
    Sadrkhanloo, Mehrdokht
    Entezari, Maliheh
    Rashidi, Mohsen
    Hashemi, Mehrdad
    Raesi, Rasoul
    Saghari, Sam
    Daneshi, Salman
    Salimimoghadam, Shokooh
    Hushmandi, Kiavash
    Mirzaei, Sepideh
    Taheriazam, Afshin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 932
  • [45] Role of macrophages in tumour progression
    Siveen, K. S.
    Kuttan, Girija
    IMMUNOLOGY LETTERS, 2009, 123 (02) : 97 - 102
  • [46] Role of osteopontin in tumour progression
    S R Rittling
    A F Chambers
    British Journal of Cancer, 2004, 90 : 1877 - 1881
  • [47] A role for neoneurogenesis in tumour progression?
    Sarah Payton
    Nature Reviews Urology, 2013, 10 (9) : 491 - 491
  • [48] Role of osteopontin in tumour progression
    Rittling, SR
    Chambers, AF
    BRITISH JOURNAL OF CANCER, 2004, 90 (10) : 1877 - 1881
  • [49] Role of RGD-binding Integrins in ovarian cancer progression, metastasis and response to therapy
    Ranga, Vipin
    Dakal, Tikam Chand
    Maurya, Pawan Kumar
    Johnson, Mark S.
    Sharma, Narendra Kumar
    Kumar, Abhishek
    INTEGRATIVE BIOLOGY, 2025, 17
  • [50] The Role of Radiation Therapy for Metastatic Cervical Cancer
    Wu, F.
    Tang, X.
    Zhang, Y.
    Wei, L.
    Wang, T.
    Lu, Z.
    Wei, J.
    Ma, S.
    Jiang, L.
    Gao, T.
    Huang, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E555 - E555
12345